Status:
UNKNOWN
Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments
Lead Sponsor:
Consorzio Oncotech
Conditions:
Metastatic Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Breast cancer is the most common cancer in many countries: in Italy about 48.000 new breast cancers are diagnosed every year and, despite improvements in diagnosis and therapy, about 13.000 women die ...
Detailed Description
The primary objectives are to evaluate the duration of metastatic breast cancer treatments (chemotherapy, hormonal therapy and biological therapies) according to biological subtype (Luminal A, Luminal...
Eligibility Criteria
Inclusion
- Retrospective cohort All consecutive metastatic breast cancers patients treated in the participating site with a first-line therapy (chemotherapy or hormonal therapy with or without biological therapy) from last contact with patient or death which ever event comes first retrospectively back until 1 st of January 2000
- Prospective cohort All new consecutive metastatic breast cancers patients will be treated in the participating site with a first-line therapy (chemotherapy or hormonal therapy with or without biological therapy)from site activation to June 2023.
- For the ancillary study
- Patients eligible for GIM 14 - BIO-META study
- HR+ HER2- patients newly diagnosed for mBC receiving CDk4/6 inhibitors as first-line or second-line treatment
- Written informed consent
Exclusion
- Not consecutive metastatic breast cancer patients grouped for a particular biological type (for example: all HER2 positive patients).
Key Trial Info
Start Date :
November 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT02284581
Start Date
November 1 2015
End Date
December 1 2025
Last Update
November 13 2023
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro di Riferimento Oncologico
Aviano, Italy, 33081
2
A.O. Consorziale Policlinico di Bari
Bari, Italy, 70124
3
A.O.U. Cagliari
Cagliari, Italy, 09122
4
Fondazione del Piemonte per l'Oncologia - I.R.C.C.
Candiolo, Italy, 10060